Last updated at 10 Jan 2025 08:08 AM
Director
DIN: 01399424
Sushen Chattopadhyay is currently associated with 5 companies in various capacities such as Director and Designated Partner. They serve as a Director at EASTERN NEURO- CARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01399424.Sushen Chattopadhyay is currently involved in 2 different roles. Their most recent position is with FIRST CURE PHARMACY LLP as a Designated Partner. The first company Sushen Chattopadhyay was appointed to as a director was EASTERN NEURO- CARE PRIVATE LIMITED. Sushen Chattopadhyay is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sushen Chattopadhyay is currently associated with 5 companies in various capacities such as Director and Designated Partner. They serve as a Director at EASTERN NEURO- CARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01399424.Sushen Chattopadhyay is currently involved in 2 different roles. Their most recent position is with FIRST CURE PHARMACY LLP as a Designated Partner. The first company Sushen Chattopadhyay was appointed to as a director was EASTERN NEURO- CARE PRIVATE LIMITED. Sushen Chattopadhyay is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
5
Male
India
Gain instant access to verified contact details.
Current Companies (4)
Current LLPs (1)
Past Companies (0)
4y 9m 2y 5m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| EASTERN NEURO- CARE PRIVATE LIMITED | Director | 04-Apr-2002 |
| SHRISTI COM PRIVATE LIMITED | Director | 24-Jun-2007 |
| NORBE MEDICARE PRIVATE LIMITED | Director | 11-Jan-2018 |
| NEURO PANACEA HOSPITALS PRIVATE LIMITED | Director | 25-Aug-2023 |